Exact Mass: 379.356244

Exact Mass Matches: 379.356244

Found 34 metabolites which its exact mass value is equals to given mass value 379.356244, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-Linoleoyl Valine

2-[(1-Hydroxyoctadeca-9,12-dien-1-ylidene)amino]-3-methylbutanoate

C23H41NO3 (379.3086276)


N-linoleoyl valine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Linoleic acid amide of Valine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Linoleoyl Valine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Linoleoyl Valine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

(+-)-Oncinotin|(+/-)-Oncinotin|(-)-oncinotine|(R)-(-)-oncinotine|(R)-8-(4-amino-butyl)-octadecahydro-4a,8-diaza-benzocycloheptadecen-9-one|(R)-Oncinotine|(??)-Oncinotine|Oncinotin|oncinotine

(+-)-Oncinotin|(+/-)-Oncinotin|(-)-oncinotine|(R)-(-)-oncinotine|(R)-8-(4-amino-butyl)-octadecahydro-4a,8-diaza-benzocycloheptadecen-9-one|(R)-Oncinotine|(??)-Oncinotine|Oncinotin|oncinotine

C23H45N3O (379.356244)


   

(()-Neooncinotine

(()-Neooncinotine

C23H45N3O (379.356244)


   
   

Solanida-3,5-dien|solanida-3,5-diene|Solanthrene

Solanida-3,5-dien|solanida-3,5-diene|Solanthrene

C27H41N (379.32388260000005)


   

(-)-isooncinotine|docosahydro-4a,9,13-triaza-benzocyclodocosen-14-one|Isooncinotin

(-)-isooncinotine|docosahydro-4a,9,13-triaza-benzocyclodocosen-14-one|Isooncinotin

C23H45N3O (379.356244)


   

Solanthren

(1S,2S,10R,11S,14S,15R,16S,17R,20S,23S)-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.02,11.05,10.015,23.017,22]tetracosa-4,6-diene

C27H41N (379.32388260000005)


   
   

N-oleoyl proline

N-(9Z-octadecenoyl)-proline

C23H41NO3 (379.3086276)


   

N-linoleoyl valine

N-(9Z,12Z-octadecadienoyl)-valine

C23H41NO3 (379.3086276)


   

NA 23:3;O2

N-(9Z,12Z-octadecadienoyl)-valine

C23H41NO3 (379.3086276)


   

N,N,N-Tributyl-1-butanaminium salicylate

N,N,N-Tributyl-1-butanaminium salicylate

C23H41NO3 (379.3086276)


   

Lithium tris[(3-ethyl-3-pentyl)oxy]aluminohydride

Lithium tris[(3-ethyl-3-pentyl)oxy]aluminohydride

C21H45AlLiO3 (379.33439799999996)


   
   

3-methyl-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]butanoic acid

3-methyl-2-[[(9E,12E)-octadeca-9,12-dienoyl]amino]butanoic acid

C23H41NO3 (379.3086276)


   

(13Z,16Z)-N-(2-hydroxyethyl)docosa-13,16-dienamide

(13Z,16Z)-N-(2-hydroxyethyl)docosa-13,16-dienamide

C24H45NO2 (379.345011)


   

N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]nonanamide

N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]nonanamide

C23H41NO3 (379.3086276)


   

N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]octanamide

N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]octanamide

C23H41NO3 (379.3086276)


   

N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]pentanamide

N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]pentanamide

C23H41NO3 (379.3086276)


   

N-[(4E,8E,12E)-1,3-dihydroxyicosa-4,8,12-trien-2-yl]propanamide

N-[(4E,8E,12E)-1,3-dihydroxyicosa-4,8,12-trien-2-yl]propanamide

C23H41NO3 (379.3086276)


   

N-[(4E,8E,12E)-1,3-dihydroxynonadeca-4,8,12-trien-2-yl]butanamide

N-[(4E,8E,12E)-1,3-dihydroxynonadeca-4,8,12-trien-2-yl]butanamide

C23H41NO3 (379.3086276)


   

N-[(4E,8E,12E)-1,3-dihydroxyhenicosa-4,8,12-trien-2-yl]acetamide

N-[(4E,8E,12E)-1,3-dihydroxyhenicosa-4,8,12-trien-2-yl]acetamide

C23H41NO3 (379.3086276)


   

N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]hexanamide

N-[(4E,8E,12E)-1,3-dihydroxyheptadeca-4,8,12-trien-2-yl]hexanamide

C23H41NO3 (379.3086276)


   

N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]heptanamide

N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]heptanamide

C23H41NO3 (379.3086276)


   

pentacosenoate

pentacosenoate

C25H47O2 (379.35758619999996)


A monounsaturated fatty acid anion with a chain that is composed of 25 carbons and 1 double bond (position unspecified).

   

2-hydroxytetracosadienoate

2-hydroxytetracosadienoate

C24H43O3 (379.32120280000004)


A 2-hydroxy fatty acid anion with a chain that is composed of 24 carbons and 2 double bond (positions unspecified).

   

NA-Ala 20:2(11Z,14Z)

NA-Ala 20:2(11Z,14Z)

C23H41NO3 (379.3086276)


   
   

NA-Ile 17:2(9Z,12Z)

NA-Ile 17:2(9Z,12Z)

C23H41NO3 (379.3086276)


   

NA-Leu 17:2(9Z,12Z)

NA-Leu 17:2(9Z,12Z)

C23H41NO3 (379.3086276)


   

NA-Val 18:2(9E,12E)

NA-Val 18:2(9E,12E)

C23H41NO3 (379.3086276)


   

NA-Val 18:2(9Z,12Z)

NA-Val 18:2(9Z,12Z)

C23H41NO3 (379.3086276)


   

(21ar)-10-(3-aminopropyl)-octadecahydro-1h-pyrido[1,2-f]1,6-diazacyclooctadecan-11-one

(21ar)-10-(3-aminopropyl)-octadecahydro-1h-pyrido[1,2-f]1,6-diazacyclooctadecan-11-one

C23H45N3O (379.356244)